Zoetis Inc.
Zoetis Inc.
ZTS
Valuace
26
Růst
75
Zdraví
83
Cena
$ 119.67
Dnes
--0.63 (-0.50%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
52.7B
Obrat
9B
Zisk
3B
Aktiva
15B
Dluh
7B
ROE
0%
ROA
0%
PE
19
PS
5
Cena 1R
115-177
⌀ Cena
145.40
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
12-02-2026
Nadcházející dividenda
20-04-2026

Profil

Zoetis Inc. objevuje, vyvíjí, vyrábí a komerčně využívá veterinární léčivé přípravky, vakcíny a diagnostické produkty ve Spojených státech i v mezinárodním měřítku. Komercializuje produkty především napříč druhy, včetně dobytka, prasat, drůbeže, ryb a ovcí, a zvířat v doprovodu psů, koček a koní. Společnost také nabízí vakcíny, které jsou biologickými přípravky k prevenci onemocnění dýchacích, gastrointestinálních a reprodukčních cest nebo k vyvolání specifické imunitní reakce; antiinfekční přípravky, které zabraňují, usmrcují nebo zpomalují růst bakterií, hub nebo prvoků; a paraziticidy, které zabraňují nebo eliminují vnější a vnitřní parazity, mezi něž patří blechy, klíšťata a červy. Poskytuje také další farmaceutické produkty, které zahrnují bolest a sedaci, antiemetické, reprodukční a onkologické produkty, dermatologické produkty pro svědění spojené s alergickými stavy a atopickou dermatitidou a medikované doplňkové látky v krmivech, které nabízejí léčiva dobytku. Kromě toho společnost poskytuje přenosné testy na analýzu krve a moči, včetně diagnostických výrobků, přístrojů a činidel v místě péče, rychlé imunotesty, referenční laboratorní sestavy a služby a monitory hladiny glukózy v krvi; a další nefarmaceutické výrobky, včetně služeb v oblasti výživy a agropodnikání, jakož i výrobky a služby v oblastech, jako jsou biologická zařízení, genetické testy a přesné zdraví zvířat. Své produkty prodává prostřednictvím svých obchodních zástupců veterinárním lékařům, chovatelům hospodářských zvířat a maloobchodním prodejnám, jakož i veterinárním distributorům třetích stran a odborníkům na technické a veterinární operace. Společnost byla založena v roce 1952 a sídlí v Parsippany v New Jersey.
Sektor
Healthcare
Odvětví
Drug Manufacturers - Specialty & Generic
Počet zaměstnanců
13800
Založení
2013-02-01
Adresa
10 Sylvan Way
CEO
Kristin C. Peck

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues9,467.09,467.09,256.08,544.08,080.07,776.06,675.06,260.05,825.05,307.04,888.04,765.04,785.04,561.04,336.04,233.03,582.0
Cost of Revenues2,794.02,794.02,860.02,710.02,454.02,303.02,057.01,992.01,911.01,775.01,666.01,738.01,717.01,669.01,563.01,652.01,444.0
Gross Profit6,673.06,673.06,396.05,834.05,626.05,473.04,618.04,268.03,914.03,532.03,222.03,027.03,068.02,892.02,773.02,581.02,138.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues2,387.02,400.02,460.02,220.02,317.02,388.02,361.02,190.02,213.02,151.0
Cost of Revenues743.0715.0682.0654.0741.0736.0703.0680.0765.0638.0
Gross Profit1,644.01,685.01,778.01,566.01,576.01,652.01,658.01,510.01,448.01,513.0
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0614.0539.0508.0463.0457.0432.0382.0376.0364.0396.0399.0409.0427.0411.0
Selling General & Admin Expenses0.00.00.02,151.02,009.02,001.01,726.01,638.01,484.01,334.01,364.01,532.01,643.01,613.01,470.01,453.01,382.0
Depreciation & Amortization487.0487.0497.0491.0150.0161.0441.0155.0117.091.085.061.060.060.0200.0205.0185.0
Total Operating Expenses3,076.03,076.03,004.02,765.02,698.02,670.02,349.02,250.02,033.01,807.01,825.01,957.02,099.02,072.01,943.01,949.01,851.0
Operating Income3,597.03,597.03,392.03,069.02,888.02,755.02,288.02,075.01,881.01,725.01,397.01,070.0969.0820.0830.0632.0287.0
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.0174.0152.0
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0565.0525.0
Depreciation & Amortization121.0124.0123.0119.0123.0121.0127.0126.0126.0124.0
Total Operating Expenses818.0749.0789.0720.0811.0732.0752.0709.0739.0715.0
Operating Income826.0936.0989.0846.0765.0920.0906.0801.0709.0836.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income93.093.0106.0105.050.06.012.037.031.00.00.00.00.00.00.00.00.0
Interest Expense238.0243.0242.0239.0221.0224.0231.0223.0206.0175.0166.0124.0117.0113.031.036.037.0
Other Expense-237.0-237.0-259.0-133.0-232.0-267.0-292.0-274.015.0-25.0-3.0-401.0-32.0-17.0-89.0-202.0-72.0
IBT3,360.03,360.03,133.02,936.02,656.02,488.01,996.01,801.01,690.01,525.01,228.0545.0820.0690.0710.0394.0178.0
Income Tax Expense687.0687.0637.0596.0545.0454.0360.0301.0266.0663.0409.0206.0233.0187.0274.0146.067.0
Net Income2,673.02,673.02,486.02,344.02,114.02,037.01,638.01,500.01,428.0864.0821.0339.0583.0504.0436.0245.0110.0
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income25.026.019.023.027.023.024.032.026.023.0
Interest Expense57.064.058.059.056.061.063.062.067.059.0
Other Expense-65.0-49.0-87.0-36.0-33.0-46.0-126.0-54.0-80.0-119.0
IBT761.0887.0902.0810.0732.0874.0780.0747.0650.0717.0
Income Tax Expense158.0166.0184.0179.0151.0182.0156.0148.0127.0121.0
Net Income603.0721.0718.0631.0581.0682.0624.0599.0525.0596.0
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$5.08$4.51$4.29$3.44$3.14$2.96$1.76$1.66$0.68$1.16$1.01$0.87$0.51$0.23
EPS Diluted$0.00$0.00$0.00$5.07$4.49$4.27$3.42$3.11$2.93$1.75$1.65$0.68$1.16$1.01$0.87$0.51$0.23
Shares Outstanding438.2443.4454.2461.2468.9474.3475.5478.1483.1489.9495.7499.7501.1500.0500.0478.1478.1
Diluted Shares Outstanding438.6443.8454.8462.3470.4476.7478.6481.8486.9493.2498.2502.0502.0500.3500.0481.8481.8
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.14$1.29
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1.14$1.29
Shares Outstanding438.2442.9445.1447.6450.5452.9455.5458.0459.0460.3
Diluted Shares Outstanding438.6443.2445.5448.0451.1453.5456.0458.8460.1461.4
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents1,574.01,985.02,041.03,577.03,482.03,602.01,932.01,602.01,564.0727.01,154.0882.0610.0317.079.063.0
Short Term Investments0.00.00.00.00.00.00.099.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments1,574.01,985.02,041.03,577.03,482.03,602.01,932.01,701.01,564.0727.01,154.0882.0610.0317.079.063.0
Accounts Receivable1,383.01,316.01,304.01,215.01,133.01,013.01,086.01,036.0998.0913.0937.0980.01,138.0900.0871.0773.0
Inventory2,452.02,306.02,564.02,345.01,923.01,628.01,410.01,391.01,427.01,502.01,467.01,289.01,293.01,345.01,063.0995.0
Other Current Assets793.0379.0434.0365.0389.0366.0318.0271.0228.0248.0201.0205.0219.0201.0202.0188.0
Total Current Assets6,202.05,986.06,343.07,506.06,930.06,611.04,748.04,399.04,217.03,390.03,830.03,465.03,357.02,864.02,311.02,116.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents2,084.01,435.01,721.01,985.01,710.01,573.01,973.02,041.01,751.01,714.0
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments2,084.01,435.01,721.01,985.01,710.01,573.01,973.02,041.01,751.01,714.0
Accounts Receivable1,541.01,540.01,361.01,316.01,411.01,383.01,293.01,304.01,257.01,322.0
Inventory2,465.02,439.02,365.02,306.02,416.02,452.02,651.02,564.02,744.02,701.0
Other Current Assets493.0509.0430.0379.0745.0794.0442.0434.0467.0443.0
Total Current Assets6,583.05,923.05,877.05,986.06,282.06,202.06,359.06,343.06,222.06,183.0
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment3,422.03,610.03,434.02,973.02,603.02,394.02,129.01,658.01,435.01,381.01,307.01,318.01,295.01,241.01,243.01,148.0
Goodwill2,739.02,724.02,759.02,746.02,682.02,694.02,592.02,519.01,510.01,481.01,455.0976.0982.0985.0989.0934.0
Intangible Assets1,226.01,127.01,338.01,380.01,474.01,710.01,890.02,046.01,269.01,228.01,190.0727.0803.0868.0928.0924.0
Long-Term Investments15.030.023.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets195.0220.0183.0147.0111.0106.098.094.075.073.049.067.058.088.097.092.0
Total Long-Term Assets7,963.08,251.07,943.07,419.06,970.06,998.06,797.06,378.04,369.04,259.04,083.03,142.03,201.03,398.03,400.03,168.0
Total Assets14,165.014,237.014,286.014,925.013,900.013,609.011,545.010,777.08,586.07,649.07,913.06,607.06,558.06,262.05,711.05,284.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment3,892.03,839.03,661.03,610.03,521.03,422.03,476.03,434.03,318.03,235.0
Goodwill2,764.02,758.02,716.02,724.02,744.02,739.02,759.02,759.02,762.02,714.0
Intangible Assets1,040.01,075.01,082.01,127.01,186.01,226.01,295.01,338.01,398.01,252.0
Long-Term Investments1.00.00.030.00.00.00.023.036.025.0
Other Long-Term Assets292.0267.0232.0250.0215.0210.0227.0183.0180.0148.0
Total Long-Term Assets8,576.08,556.08,221.08,251.08,075.07,963.07,989.07,943.07,884.07,566.0
Total Assets15,159.014,479.014,098.014,237.014,357.014,165.014,348.014,286.014,106.013,749.0
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable420.0433.0411.0405.0436.0457.0301.0313.0261.0265.0293.0290.0506.0319.0214.0206.0
Short-Term Debt279.01,350.03.01,352.00.0604.0500.09.00.00.0405.07.015.073.00.038.0
Other Current Liabilities1,080.01,536.01,365.01,410.01,361.093.055.0866.0833.0852.063.08.0589.0507.0629.0396.0
Current Liabilities1,797.03,412.01,889.03,167.01,797.02,170.01,806.01,223.01,094.01,117.01,781.01,086.01,415.01,123.0843.0808.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable410.0508.0420.0433.0404.0420.0405.0411.0388.0464.0
Short-Term Debt0.01,350.01,350.01,350.00.00.024.03.02.02.0
Other Current Liabilities1,233.01,415.01,404.01,536.01,201.01,295.01,250.01,365.01,074.01,216.0
Current Liabilities1,807.03,366.03,385.03,412.01,702.01,797.01,909.01,889.01,608.01,769.0
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt6,563.05,394.06,752.06,738.06,743.06,758.06,111.06,443.04,953.04,468.04,463.03,643.03,642.0509.0575.0673.0
Capital Leases181.0174.0188.0186.0151.0163.0164.00.00.00.00.00.00.00.00.00.0
Def. Tax Liability175.0167.0146.0142.0320.0378.0434.0474.0380.0244.0264.0277.0322.0323.0311.0218.0
Total Liabilities9,205.09,467.09,295.010,522.09,356.09,836.08,837.08,592.06,800.06,150.06,822.05,270.05,596.02,221.01,975.01,940.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt7,273.05,441.05,400.05,394.06,755.06,744.06,746.06,752.06,743.06,743.0
Capital Leases204.0210.0173.0174.0181.0181.0184.0188.0191.0188.0
Def. Tax Liability147.0156.0161.0167.0172.0175.0136.0146.0160.0121.0
Total Liabilities9,761.09,502.09,443.09,467.09,123.09,205.09,296.09,295.09,032.09,128.0
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock5.05.05.05.05.05.05.05.05.05.05.05.05.00.00.00.0
Retained Earnings11,124.011,968.010,295.08,668.07,186.05,659.04,427.03,270.02,109.01,477.0876.0709.0276.00.00.00.0
Comprehensive Income-845.0-940.0-839.0-817.0-764.0-730.0-726.0-629.0-505.0-598.0-622.0-361.0-219.0-157.0-65.0-74.0
Total Common Equity4,966.04,770.04,997.04,405.04,543.03,769.02,708.02,185.01,770.01,487.01,068.01,311.0940.04,026.03,720.03,344.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock5.05.05.05.05.05.05.05.05.05.0
Retained Earnings13,593.012,872.012,375.011,968.011,806.011,124.010,696.010,295.010,140.09,543.0
Comprehensive Income-818.0-877.0-1,017.0-940.0-851.0-845.0-841.0-839.0-814.0-895.0
Total Common Equity5,398.04,977.04,655.04,770.05,234.04,966.05,058.04,997.05,078.04,625.0
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt6,744.06,744.06,755.08,090.06,743.07,362.06,611.06,452.04,953.04,468.04,868.03,650.03,657.0582.0575.0711.0
Book Value4,960.04,770.04,991.04,403.04,544.03,773.02,708.02,185.01,786.01,499.01,091.01,337.0962.04,041.03,736.03,344.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.0-6.0-6.0-6.0-4.0-4.0
Book Value5,398.04,977.04,655.04,770.05,234.04,966.05,058.04,997.05,078.04,625.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income2,344.02,673.02,496.02,344.02,111.02,034.01,636.01,500.01,424.0862.0819.0339.0587.0503.0436.0248.0111.0
Depreciation & Amortization503.0487.0497.0491.0465.0448.0441.0412.0308.0242.0240.0199.0204.0209.0200.0205.0185.0
Stock-Based Compensation71.083.074.060.062.058.059.067.053.044.037.043.032.043.028.019.016.0
Change Working Capital-206.0-408.079.0-512.0-699.0-343.0-85.0-151.0112.0-29.0-439.0-208.0-157.0-104.0-149.0-117.0100.0
Change In Accounts Receivable-98.0-236.0-61.0-102.0-137.0-155.074.0-69.0-67.0-50.015.0-58.069.0-99.0-65.0-85.030.0
Change In Accounts Payable-32.046.031.013.0-29.0-17.0147.0-10.037.0-10.0-28.017.0-210.0-82.096.0-16.025.0
Change In Inventories-52.0-199.0-40.0-361.0-486.0-366.0-346.0-104.061.019.0-101.0-262.0-16.0-104.0-318.040.0117.0
Other Non-cash Items935.0121.0145.031.0259.096.0137.046.05.0100.0111.0376.09.07.013.077.0-90.0
Cash from Operations2,718.00.00.02,353.01,912.02,213.02,126.01,795.01,790.01,346.0713.0664.0626.0681.0454.0497.0254.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income603.0721.0718.0631.0581.0692.0624.0599.0525.0596.0
Depreciation & Amortization121.0124.0123.0119.0123.0121.0127.0126.0126.0124.0
Stock-Based Compensation22.022.022.017.019.018.019.018.017.017.0
Change Working Capital170.054.0-415.0-217.0309.0360.0-239.0-121.0202.0-48.0
Change In Accounts Receivable-52.010.0-141.0-53.073.0-22.0-100.0-12.0-48.062.0
Change In Accounts Payable76.0-54.036.0-12.026.0-15.023.0-3.022.0-74.0
Change In Inventories13.0-44.0-83.0-85.073.02.0-17.0-98.0136.0-73.0
Other Non-cash Items25.033.045.018.025.0-198.072.016.048.049.0
Cash from Operations0.00.00.00.00.00.00.00.0897.0724.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-615.0-621.0-655.0-732.0-586.0-477.0-453.0-460.0-338.0-224.0-216.0-224.0-195.0-184.0-126.0-135.0-124.0
Acquisitions-248.0-24.0285.0-59.0-312.0-14.0-113.0-195.0-1,998.0-82.0-88.0-883.00.0-4.00.0-345.0-81.0
Investments-5.0-7.0-5.0-4.0-9.0-12.0-27.0460.0338.00.00.00.00.00.00.00.00.0
Sales of Investment30.00.00.012.023.044.0453.0138.028.00.00.00.00.00.00.00.00.0
Other Investing Activities41.00.00.06.01.01.0-432.0-447.0-289.036.090.0-8.08.09.0-9.031.0196.0
Cash from Investing-744.00.00.0-777.0-883.0-458.0-572.0-504.0-2,259.0-270.0-214.0-1,115.0-187.0-179.0-135.0-449.0-9.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-161.0-133.0-178.0-149.0-216.0-167.0-132.0-140.0-198.0-145.0
Acquisitions-14.0-10.00.00.0293.0-1.0-8.01.0-96.0-145.0
Investments11.073.0-52.0-27.0-1.0-1.0-2.0-1.0-1.0-1.0
Sales of Investment0.00.00.00.051.0-10.011.010.0-11.020.0
Other Investing Activities0.00.00.00.00.00.00.00.096.0-74.0
Cash from Investing0.00.00.00.00.00.00.00.0-210.0-271.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-46.00.00.0-1,349.0-10.0-600.0-500.00.00.0-750.0-400.0-119.00.00.00.0-143.00.0
Debt Issued6,790.06,744.0-11.014.01,357.0-19.01,251.0159.01,499.01,235.00.01,337.0-7.03,075.07.07.0711.0
Issuance of Common Stock2.00.00.00.00.0-39.01,244.00.00.01,231.0-5.01,234.00.00.00.00.00.0
Repurchase of Common Stock-1,357.0-3,235.0-1,858.0-1,092.0-1,594.0-743.0-250.0-626.0-698.0-500.0-300.0-203.00.00.00.00.00.0
Dividends Paid-740.00.00.0-692.0-611.0-474.0-380.0-314.0-243.0-206.0-188.0-168.0-146.0-98.0-63.0-416.0-207.0
Other Financing Activities-1.00.00.024.01,311.0-6.09.0-11.01,474.0-26.0-10.011.0-8.0-102.0-15.0529.0-70.0
Cash from Financing-2,100.00.00.0-3,109.0-904.0-1,862.0123.0-951.0533.0-251.0-903.0755.0-154.0-200.0-78.0-30.0-277.0
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.01.00.0
Debt Issued7,273.0482.041.06.0-11.011.0-26.0-33.059.06,745.0
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-2,060.0-394.0-338.0-443.0-553.0-433.0-533.0-339.0-235.0-250.0
Dividends Paid0.00.00.00.00.00.00.00.0-172.0-173.0
Other Financing Activities0.00.00.00.00.00.00.00.09.07.0
Cash from Financing0.00.00.00.00.00.00.00.0-397.0-416.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-143.0325.0-54.0-1,540.096.0-119.01,670.0332.038.0837.0-427.0272.0272.0293.0238.016.0-36.0
Closing Cash Balance1,574.02,312.01,987.02,041.03,581.03,485.03,604.01,934.01,602.01,564.0727.01,154.0882.0610.0317.079.063.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash228.0649.0-286.0-266.0273.0140.0-401.0-66.0287.037.0
Closing Cash Balance2,312.02,084.01,435.01,721.01,987.01,714.01,574.01,975.02,041.01,754.0
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow2,103.02,283.02,298.01,621.01,326.01,736.01,673.01,335.01,452.01,122.0497.0440.0431.0497.0328.0362.0130.0
Real Free Cash Flow2,032.02,200.02,224.01,561.01,264.01,678.01,614.01,268.01,399.01,078.0460.0397.0399.0454.0300.0343.0114.0
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow732.0805.0308.0438.0689.0784.0370.0455.0699.0579.0
Real Free Cash Flow710.0783.0286.0421.0670.0766.0351.0437.0682.0562.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E1939.12356.8
P/S5.47.670.5
P/B9.418.32015.4
P/FCF23.148.27573.5
Market cap$52.7$66.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %47.3 %0 %
Debt to Income272.1 %457.8 %0 %
Debt to Free cash flow330.6 %19.6 %0 %
Interest expense percentage6.6 %9.2 %0 %
Current ratio3.6 2.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE49.5 %41.9 %0 %
ROA17.6 %10.7 %0 %
CapEx to Revenue6.6 %5.4 %0 %
RaD to Revenue0 %7.5 %0 %
ROEM686,014.5 1192776.7

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin70.5 %66.6 %67.7 %
Operating margin38 %28.5 %-263.4 %
Net margin28.2 %18.7 %-255.6 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.6 %0 %
Dividend payout percentage0 %31.9 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding438.6 mil 482.1 mil
Employee count13.8 tis 8.9 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader